Asian Dengue Vaccination Advocacy Symposium at the 8th Asian Congress of Paediatric Infectious Diseases 2016

October 12, 2016
Event Date   : 9 Nov 2016Event Venue: Queen Sirikit Convention                            Centre,Bangkok, ThailandSymposium Title: From Dengue Vaccine                             to Dengue VaccinationTime               : 13.30 – 15.00

Singapore to make Dengue Vaccine Soon available – HSA reports:

October 4, 2016
SINGAPORE – The Health Sciences Authority (HSA) has approved the world’s first dengue vaccine Dengvaxia for use in Singapore following a seven-month expedited review of the potential […]

Upward trend in number of dengue cases in Singapore

July 27, 2016
Dengue fever cases are creeping up again as Singapore enters the traditional peak dengue season, with the number of cases exceeding 200 a week for the fourth […]

Asean urged to fight dengue together

June 16, 2016
The rising incidence of dengue fever in Asean has prompted health experts to call for a collective regional action to fight the fastest- growing mosquito-borne disease.

ADVA congratulates Dr. Garin, Honorable Health Secretary, Republic of the Philippines on the launch of the first mass dengue vaccination programme

April 4, 2016
The Philippines leads the path to better dengue management with the world's first mass vaccination programme for dengue fever. ADVA is pleased to congratulate Dr. Loreto-Garin, Health Secretary and the people involved for their accomplishment.

First dengue vaccine, Dengvaxia®, awarded ‘The Vaccine Breakthrough of 2016’

April 4, 2016
The world’s first dengue vaccine, Dengvaxia®, was awarded ‘The Vaccine Breakthrough of 2016’ at the 6th annual Biopharma Industry Awards Event last night. Developed by Sanofi Pasteur, Dengvaxia® is the world’s first vaccine licensed for the prevention of dengue caused by all four serotypes in individuals between nine and 45 years of age.